4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-014986
President & COO sold 100,000 shares at $10.22 ($1,022,000)
- President & COO acquired 100,000 shares (option exercise)
- President & COO gave up 10,945 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric President & COO | 2025-04-20 | Shares withheld for taxes 10b5-1 | −10,945 | $10.15 | $111,092 | 1,116,345 | D |
| Venker Eric President & COO | 2025-04-21 | Option exercise 10b5-1 | +100,000 | $3.85 | $385,000 | 1,216,345 | D |
| Venker Eric President & COO | 2025-04-21 | Sale 10b5-1 | −100,000 | $10.22 | $1,022,000 | 1,116,345 | D |
| Derivatives | |||||||
| Venker Eric President & COO | 2025-04-21 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 9,823,923 | D | ||
| Open-market sales · 100,000 sh · avg $10.22 · $1,022,000 | |||||||
Loading xslF345X05/form4.xml…